Nanocrystal targeting in vivo. Åkerman, M. E., Chan, W. C. W., Laakkonen, P., Bhatia, S. N., & Ruoslahti, E. PNAS, 99(20):12617–12621, October, 2002. Publisher: National Academy of Sciences Section: Biological Sciences
Nanocrystal targeting in vivo [link]Paper  doi  abstract   bibtex   
Inorganic nanostructures that interface with biological systems have recently attracted widespread interest in biology and medicine. Nanoparticles are thought to have potential as novel intravascular probes for both diagnostic (e.g., imaging) and therapeutic purposes (e.g., drug delivery). Critical issues for successful nanoparticle delivery include the ability to target specific tissues and cell types and escape from the biological particulate filter known as the reticuloendothelial system. We set out to explore the feasibility of in vivo targeting by using semiconductor quantum dots (qdots). Qdots are small (\textless10 nm) inorganic nanocrystals that possess unique luminescent properties; their fluorescence emission is stable and tuned by varying the particle size or composition. We show that ZnS-capped CdSe qdots coated with a lung-targeting peptide accumulate in the lungs of mice after i.v. injection, whereas two other peptides specifically direct qdots to blood vessels or lymphatic vessels in tumors. We also show that adding polyethylene glycol to the qdot coating prevents nonselective accumulation of qdots in reticuloendothelial tissues. These results encourage the construction of more complex nanostructures with capabilities such as disease sensing and drug delivery.
@article{akerman_nanocrystal_2002,
	title = {Nanocrystal targeting in vivo},
	volume = {99},
	copyright = {Copyright © 2002, The National Academy of Sciences},
	issn = {0027-8424, 1091-6490},
	url = {http://www.pnas.org/content/99/20/12617},
	doi = {10.1073/pnas.152463399},
	abstract = {Inorganic nanostructures that interface with biological systems have recently attracted widespread interest in biology and medicine. Nanoparticles are thought to have potential as novel intravascular probes for both diagnostic (e.g., imaging) and therapeutic purposes (e.g., drug delivery). Critical issues for successful nanoparticle delivery include the ability to target specific tissues and cell types and escape from the biological particulate filter known as the reticuloendothelial system. We set out to explore the feasibility of in vivo targeting by using semiconductor quantum dots (qdots). Qdots are small ({\textless}10 nm) inorganic nanocrystals that possess unique luminescent properties; their fluorescence emission is stable and tuned by varying the particle size or composition. We show that ZnS-capped CdSe qdots coated with a lung-targeting peptide accumulate in the lungs of mice after i.v. injection, whereas two other peptides specifically direct qdots to blood vessels or lymphatic vessels in tumors. We also show that adding polyethylene glycol to the qdot coating prevents nonselective accumulation of qdots in reticuloendothelial tissues. These results encourage the construction of more complex nanostructures with capabilities such as disease sensing and drug delivery.},
	language = {en},
	number = {20},
	urldate = {2021-11-06},
	journal = {PNAS},
	author = {Åkerman, Maria E. and Chan, Warren C. W. and Laakkonen, Pirjo and Bhatia, Sangeeta N. and Ruoslahti, Erkki},
	month = oct,
	year = {2002},
	pmid = {12235356},
	note = {Publisher: National Academy of Sciences
Section: Biological Sciences},
	pages = {12617--12621},
	file = {Full Text PDF:files/2285/Åkerman et al. - 2002 - Nanocrystal targeting in vivo.pdf:application/pdf;Snapshot:files/2288/12617.html:text/html},
}

Downloads: 0